RENAISSANCE TECHNOLOGIES LLC

Position in RPRX — Royalty Pharma plc

CIK 1037389 NEW YORK, NY

Position in RPRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$37,941,247

+$37,631,777 QoQ

Shares Held

790,937

+7661.9% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. RPRX ranks #17 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,941,247	790,937	+7661.9%	Shares	Sole	2026-05-14
2024-03-31	$309,470	10,190	-97.9%	Shares	Sole	2024-05-13
2023-09-30	$13,114,048	483,200	-37.3%	Shares	Sole	2023-11-14
2023-06-30	$23,691,318	770,700	-40.8%	Shares	Sole	2023-08-11
2023-03-31	$46,871,427	1,300,900	+49.7%	Shares	Sole	2023-05-12
2022-12-31	$34,342,880	869,000	+372.5%	Shares	Sole	2023-02-13
2022-03-31	$7,164,744	183,900	-77.0%	Shares	Sole	2022-05-13
2021-12-31	$31,844,135	799,100	+2.0%	Shares	Sole	2022-02-11
2021-09-30	$28,319,304	783,600	-5.4%	Shares	Sole	2021-11-12
2021-06-30	$33,964,314	828,600	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.